134 related articles for article (PubMed ID: 1721059)
1. Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase.
Banka CL; Bonnet DJ; Black AS; Smith RS; Curtiss LK
J Biol Chem; 1991 Dec; 266(35):23886-92. PubMed ID: 1721059
[TBL] [Abstract][Full Text] [Related]
2. Localization of apolipoprotein A-I epitopes involved in the activation of lecithin:cholesterol acyltransferase.
Uboldi P; Spoladore M; Fantappiè S; Marcovina S; Catapano AL
J Lipid Res; 1996 Dec; 37(12):2557-68. PubMed ID: 9017508
[TBL] [Abstract][Full Text] [Related]
3. Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.
Wong L; Curtiss LK; Huang J; Mann CJ; Maldonado B; Roheim PS
J Clin Invest; 1992 Dec; 90(6):2370-5. PubMed ID: 1281832
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase. Importance of the central domain.
Meng QH; Calabresi L; Fruchart JC; Marcel YL
J Biol Chem; 1993 Aug; 268(23):16966-73. PubMed ID: 7688720
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity.
Alexander ET; Bhat S; Thomas MJ; Weinberg RB; Cook VR; Bharadwaj MS; Sorci-Thomas M
Biochemistry; 2005 Apr; 44(14):5409-19. PubMed ID: 15807534
[TBL] [Abstract][Full Text] [Related]
7. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells.
Banka CL; Black AS; Curtiss LK
J Biol Chem; 1994 Apr; 269(14):10288-97. PubMed ID: 7511599
[TBL] [Abstract][Full Text] [Related]
8. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
Sparks DL; Frank PG; Neville TA
Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
[TBL] [Abstract][Full Text] [Related]
9. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
10. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
11. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.
Roosbeek S; Vanloo B; Duverger N; Caster H; Breyne J; De Beun I; Patel H; Vandekerckhove J; Shoulders C; Rosseneu M; Peelman F
J Lipid Res; 2001 Jan; 42(1):31-40. PubMed ID: 11160363
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
13. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
[TBL] [Abstract][Full Text] [Related]
14. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity.
Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW
J Biol Chem; 1997 Mar; 272(11):7278-84. PubMed ID: 9054424
[TBL] [Abstract][Full Text] [Related]
15. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
O K; Frohlich J
J Lipid Res; 1995 Nov; 36(11):2344-54. PubMed ID: 8656072
[TBL] [Abstract][Full Text] [Related]
16. Assignment of the binding site for haptoglobin on apolipoprotein A-I.
Spagnuolo MS; Cigliano L; D'Andrea LD; Pedone C; Abrescia P
J Biol Chem; 2005 Jan; 280(2):1193-8. PubMed ID: 15533931
[TBL] [Abstract][Full Text] [Related]
17. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
[TBL] [Abstract][Full Text] [Related]
18. Natural mutations of apolipoprotein A-I impairing activation of lecithin:cholesterol acyltransferase.
Hoang A; Huang W; Sasaki J; Sviridov D
Biochim Biophys Acta; 2003 Feb; 1631(1):72-6. PubMed ID: 12573451
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
[TBL] [Abstract][Full Text] [Related]
20. Influence of vesicle surface composition on the interfacial binding of lecithin:cholesterol acyltransferase and apolipoprotein A-I.
Miller KR; Parks JS
J Lipid Res; 1997 Jun; 38(6):1094-102. PubMed ID: 9215538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
